Imagine a better CRISPR. Xenomics is a biotechnology company that is advancing breakthroughs in genetics and biomanufacturing to combat major sustainability issues in food, energy, and health. At the heart of its technology is a next generation multi-site gene editing platform that enables biological advancement on an unparalleled scale. Xenomics combines genomics, synthetic biology, computational biology, and nanotechnology to advance the science needed to address humanity's most complex sustainability challenges—feeding, fueling, and healing society.